Reina Armamento-Villareal1, Neil Wingkun, Lina E Aguirre, Vibhati Kulkarny, Nicola Napoli, Georgia Colleluori, Clifford Qualls, Dennis T Villareal. 1. aDivision of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine bSection of Endocrinology, Michael E DeBakey VA Medical Center cCenter for Translational Research on Inflammatory Diseases (CTRID), MEDVAMC dUniversity of Texas Medical School at Houston, Houston, Texas eSection of Endocrinology, New Mexico VA Health Care System fBiomedical Research Institute of New Mexico gDivision of Mathematics and Statistics, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA hDivision of Endocrinology, University Campus Bio-Medico DiRoma, Rome, Italy.
Abstract
OBJECTIVE: Fat mass and obesity-associated (FTO) gene polymorphisms have been reported to be associated with differences in BMI, obesity, and type 2 diabetes. However, previous studies have been predominantly conducted in younger individuals across a spectrum of body weights, whereas little information is available on the older population. We examined the association of FTO gene polymorphisms with cardiometabolic risks among adults who were both obese (BMI≥30 kg/m) and older (age≥65 years). METHODS: A total of 165 frail, obese older adults were genotyped for FTO (rs9939609 and rs8050136) single nucleotide polymorphisms and studied for associations with body weight and body composition, components and prevalence of the metabolic syndrome, insulin response to an oral glucose tolerance test, and levels of adipocytokines (e.g. leptin) and vitamin D. RESULTS: Carriers of the A allele (CA/AA) of the FTO single nucleotide polymorphism rs8050136 had lower body weight, BMI, body fat, and trunk fat than those without the A allele (CC genotype; all P's<0.05). Moreover, genotype CA/AA was associated with lower levels of triglycerides and higher levels of high-density lipoprotein-cholesterol and carriers of this genotype showed a trend toward a lower waist circumference, resulting in a lower prevalence of metabolic syndrome than in CC genotype carriers. The insulin area under the curve during the oral glucose tolerance test was lower for genotype CA/AA. Despite the lower insulin levels, the glucose area under the curve was unchanged, resulting in a higher insulin sensitivity index. Leptin levels were also lower and adiponectin and 25-hydroxyvitamin levels tended to be higher for genotype CA/AA than for genotype CC. No differences were observed for rs9939609. CONCLUSION: Unlike the results from studies in younger individuals, the risk A allele may confer a favorable cardiometabolic risk profile in obese older adults, suggesting selective survival of obese adults into old age. If confirmed in a larger sample of surviving obese older adults, these findings may have implications in the clinical approach to obesity in this population.
OBJECTIVE: Fat mass and obesity-associated (FTO) gene polymorphisms have been reported to be associated with differences in BMI, obesity, and type 2 diabetes. However, previous studies have been predominantly conducted in younger individuals across a spectrum of body weights, whereas little information is available on the older population. We examined the association of FTO gene polymorphisms with cardiometabolic risks among adults who were both obese (BMI≥30 kg/m) and older (age≥65 years). METHODS: A total of 165 frail, obese older adults were genotyped for FTO (rs9939609 and rs8050136) single nucleotide polymorphisms and studied for associations with body weight and body composition, components and prevalence of the metabolic syndrome, insulin response to an oral glucose tolerance test, and levels of adipocytokines (e.g. leptin) and vitamin D. RESULTS: Carriers of the A allele (CA/AA) of the FTO single nucleotide polymorphism rs8050136 had lower body weight, BMI, body fat, and trunk fat than those without the A allele (CC genotype; all P's<0.05). Moreover, genotype CA/AA was associated with lower levels of triglycerides and higher levels of high-density lipoprotein-cholesterol and carriers of this genotype showed a trend toward a lower waist circumference, resulting in a lower prevalence of metabolic syndrome than in CC genotype carriers. The insulin area under the curve during the oral glucose tolerance test was lower for genotype CA/AA. Despite the lower insulin levels, the glucose area under the curve was unchanged, resulting in a higher insulin sensitivity index. Leptin levels were also lower and adiponectin and 25-hydroxyvitamin levels tended to be higher for genotype CA/AA than for genotype CC. No differences were observed for rs9939609. CONCLUSION: Unlike the results from studies in younger individuals, the risk A allele may confer a favorable cardiometabolic risk profile in obese older adults, suggesting selective survival of obese adults into old age. If confirmed in a larger sample of surviving obese older adults, these findings may have implications in the clinical approach to obesity in this population.
Authors: Joanne E Cecil; Roger Tavendale; Peter Watt; Marion M Hetherington; Colin N A Palmer Journal: N Engl J Med Date: 2008-12-11 Impact factor: 91.245
Authors: T Mezza; G Muscogiuri; G P Sorice; A Prioletta; E Salomone; A Pontecorvi; A Giaccari Journal: Ann Nutr Metab Date: 2012-12-03 Impact factor: 3.374
Authors: Johanna L Johnson; Cris A Slentz; Joseph A Houmard; Gregory P Samsa; Brian D Duscha; Lori B Aiken; Jennifer S McCartney; Charles J Tanner; William E Kraus Journal: Am J Cardiol Date: 2007-10-29 Impact factor: 2.778
Authors: Josefin A Jacobsson; Markus Sällman Almén; Christian Benedict; Lilia A Hedberg; Karl Michaëlsson; Samantha Brooks; Joel Kullberg; Tomas Axelsson; Lars Johansson; Håkan Ahlström; Robert Fredriksson; Lars Lind; Helgi B Schiöth Journal: PLoS One Date: 2011-05-27 Impact factor: 3.240
Authors: Christian Dina; David Meyre; Sophie Gallina; Emmanuelle Durand; Antje Körner; Peter Jacobson; Lena M S Carlsson; Wieland Kiess; Vincent Vatin; Cecile Lecoeur; Jérome Delplanque; Emmanuel Vaillant; François Pattou; Juan Ruiz; Jacques Weill; Claire Levy-Marchal; Fritz Horber; Natascha Potoczna; Serge Hercberg; Catherine Le Stunff; Pierre Bougnères; Peter Kovacs; Michel Marre; Beverley Balkau; Stéphane Cauchi; Jean-Claude Chèvre; Philippe Froguel Journal: Nat Genet Date: 2007-05-13 Impact factor: 38.330
Authors: Mariaelisa Graff; Penny Gordon-Larsen; Unhee Lim; Jay H Fowke; Shelly-Ann Love; Megan Fesinmeyer; Lynne R Wilkens; Shawyntee Vertilus; Marilyn D Ritchie; Ross L Prentice; Jim Pankow; Kristine Monroe; JoAnn E Manson; Loïc Le Marchand; Lewis H Kuller; Laurence N Kolonel; Ching P Hong; Brian E Henderson; Jeff Haessler; Myron D Gross; Robert Goodloe; Nora Franceschini; Christopher S Carlson; Steven Buyske; Petra Bůžková; Lucia A Hindorff; Tara C Matise; Dana C Crawford; Christopher A Haiman; Ulrike Peters; Kari E North Journal: Diabetes Date: 2013-01-08 Impact factor: 9.461
Authors: Angelo Scuteri; Serena Sanna; Wei-Min Chen; Manuela Uda; Giuseppe Albai; James Strait; Samer Najjar; Ramaiah Nagaraja; Marco Orrú; Gianluca Usala; Mariano Dei; Sandra Lai; Andrea Maschio; Fabio Busonero; Antonella Mulas; Georg B Ehret; Ashley A Fink; Alan B Weder; Richard S Cooper; Pilar Galan; Aravinda Chakravarti; David Schlessinger; Antonio Cao; Edward Lakatta; Gonçalo R Abecasis Journal: PLoS Genet Date: 2007-07 Impact factor: 5.917